LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B Turnover 14.78%
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
+9.71%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$6.77B
AUM Growth
+$562M
Cap. Flow
+$52.1M
Cap. Flow %
0.77%
Top 10 Hldgs %
37.57%
Holding
115
New
14
Increased
26
Reduced
50
Closed
3
Avg Time Held
5.5 years
Top 10 Avg Time Held
6.5 years
Top 20 Avg Time Held
6.6 years

Top Buys

Rank Stock Value
1
GEHC icon
GE HealthCare
GEHC
+$57.7M
2
GIL icon
Gildan
GIL
+$54.4M
3
EXC icon
Exelon
EXC
+$41.2M
4
TU icon
Telus
TU
+$33.9M
5
CMCSA icon
Comcast
CMCSA
+$30.3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$186M
2
BMO icon
Bank of Montreal
BMO
+$24.1M
3
SU icon
Suncor Energy
SU
+$16.5M
4
EFXT icon
Enerflex
EFXT
+$14.5M
5
MGA icon
Magna International
MGA
+$13.7M

Sector Composition

Rank Sector Weight
1 Financials 32.78%
2 Communication Services 16.83%
3 Healthcare 10.42%
4 Technology 9.49%
5 Materials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
STT icon
26
State Street
STT
$45.8B
$89.1M 1.32%
525,646
-18,810
-3% -$2.9M
2013 Q2
52 quarters
T icon
27
AT&T
T
$158B
$86.4M 1.28%
4,174,925
+53,225
+1% +$1.32M
2013 Q2
52 quarters
ELPC icon
28
Copel
ELPC
$10.3B
$85.4M 1.26%
7,333,972
-578,765
-7% -$7.06M
2024 Q1
9 quarters
C icon
29
Citigroup
C
$205B
$85.2M 1.26%
609,048
-22,442
-4% -$2.92M
2013 Q2
52 quarters
GSK icon
30
GSK
GSK
$95.9B
$85.2M 1.26%
1,624,668
-19,945
-1% -$1.05M
2022 Q3
15 quarters
CMCSA icon
31
Comcast
CMCSA
$74.7B
$85M 1.26%
3,460,961
+1,176,005
+51% +$30.3M
2013 Q2
52 quarters
SWKS icon
32
Skyworks Solutions
SWKS
$18.1B
$83.7M 1.24%
1,234,937
+322,240
+35% +$21.9M
2018 Q2
32 quarters
TTE icon
33
TotalEnergies
TTE
$198B
$82.2M 1.21%
1,056,594
-24,485
-2% -$2.17M
2025 Q4
2 quarters
EMN icon
34
Eastman Chemical
EMN
$7.19B
$80.3M 1.19%
1,199,240
+5,894
+0.5% +$431K
2016 Q4
38 quarters
CRM icon
35
Salesforce
CRM
$194B
$79.1M 1.17%
504,810
+148,100
+42% +$26M
2025 Q4
2 quarters
TFC icon
36
Truist Financial
TFC
$55.7B
$77.3M 1.14%
1,551,961
-15,835
-1% -$779K
2014 Q3
47 quarters
VZ icon
37
Verizon
VZ
$185B
$73.1M 1.08%
1,726,727
+24,503
+1% +$1.15M
2013 Q2
52 quarters
SBS icon
38
Sabesp
SBS
$22.6B
$70M 1.03%
12,114,373
+371,528
+3% +$2.25M
2013 Q2
52 quarters
ABBV icon
39
AbbVie
ABBV
$501B
$67.9M 1%
270,009
-5,140
-2% -$1.11M
2017 Q1
37 quarters
FDX icon
40
FedEx
FDX
$68.9B
$67.5M 1%
215,587
-1,925
-0.9% -$699K
2022 Q4
14 quarters
CRUS icon
41
Cirrus Logic
CRUS
$5.43B
$65.7M 0.97%
442,259
-7,245
-2% -$1.19M
2017 Q4
34 quarters
GEHC icon
42
GE HealthCare
GEHC
$30.9B
$56.2M 0.83%
+878,575
New +$57.7M
2026 Q2
0 quarters
BAC icon
43
Bank of America
BAC
$359B
$55.1M 0.81%
967,290
-8,150
-0.8% -$433K
2013 Q2
52 quarters
TECK icon
44
Teck Resources
TECK
$31.8B
$52.1M 0.77%
874,729
-208,033
-19% -$12.7M
2013 Q2
52 quarters
MRNA icon
45
Moderna
MRNA
$90.3B
$50.8M 0.75%
724,830
-23,985
-3% -$1.24M
2023 Q4
10 quarters
EFXT icon
46
Enerflex
EFXT
$3.15B
$49M 0.72%
1,997,788
-582,425
-23% -$14.5M
2022 Q4
14 quarters
GIL icon
47
Gildan
GIL
$7.62B
$48.8M 0.72%
+947,100
New +$54.4M
2026 Q2
0 quarters
GPK icon
48
Graphic Packaging
GPK
$2.48B
$47.1M 0.7%
4,453,305
+982,745
+28% +$10M
2022 Q2
16 quarters
WFC icon
49
Wells Fargo
WFC
$243B
$47M 0.7%
569,169
-4,650
-0.8% -$374K
2018 Q2
32 quarters
QSR icon
50
Restaurant Brands International
QSR
$25.3B
$46.6M 0.69%
643,271
-26,346
-4% -$2.01M
2021 Q1
21 quarters

Similar funds

Letko, Brosseau & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Letko, Brosseau & Associates held 115 positions worth $6.77B, up 9.1% from $6.2B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Letko, Brosseau & Associates's Q2 2026 filing shows 14 new, 26 increased, 50 reduced and 3 closed positions. Its largest new stake was GE HealthCare: 878,575 shares worth $56.2M. The largest sale was Intel, an estimated $186M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 30% a quarter earlier, followed by Communication Services and Healthcare.

  • Letko, Brosseau & Associates's largest Q2 2026 buy was GE HealthCare: 878,575 shares worth $56.2M.
  • Letko, Brosseau & Associates added most to Telus in Q2 2026, an estimated $33.9M increase.
  • Letko, Brosseau & Associates's biggest Q2 2026 reduction was Intel, cutting an estimated $186M.
  • Letko, Brosseau & Associates fully exited Alphabet (Google) Class A in Q2 2026, selling an estimated $314K.
  • Letko, Brosseau & Associates's ten largest holdings make up 38% of its $6.77B portfolio in Q2 2026.
  • Letko, Brosseau & Associates opened 14 new positions and closed 3 in Q2 2026.
  • Letko, Brosseau & Associates's portfolio value rose 9.1% quarter-over-quarter to $6.77B.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2026, filed 13 Aug 2026.